[
    [
        {
            "time": "2021-05-21",
            "original_text": "抗癌明星药PD-1出海大战：信达争夺首张海外“门票”，目前落后君实“半个身位”",
            "features": {
                "keywords": [
                    "PD-1",
                    "信达生物",
                    "君实生物",
                    "海外市场"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "抗癌明星药PD-1出海大战：信达争夺首张海外“门票”，目前落后君实“半个身位”",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "北向资金 | 合计净流出5.78亿元，中国平安、三一重工、恒瑞医药净卖出居前",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "中国平安",
                    "三一重工",
                    "恒瑞医药"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药",
                    "机械制造"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金 | 合计净流出5.78亿元，中国平安、三一重工、恒瑞医药净卖出居前",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "北向资金小幅净卖出近6亿元，三一重工连续7日净卖出",
            "features": {
                "keywords": [
                    "北向资金",
                    "净卖出",
                    "三一重工"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "机械制造"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金小幅净卖出近6亿元，三一重工连续7日净卖出",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "医药生物行业2020年及2021年一季度业绩综述：2020年营收增速有所下降 2021Q1业绩大幅回升",
            "features": {
                "keywords": [
                    "医药生物",
                    "2020年",
                    "2021Q1",
                    "营收增速",
                    "业绩回升"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2020年及2021年一季度业绩综述：2020年营收增速有所下降 2021Q1业绩大幅回升",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "北向资金动向盘点：白酒抱团强化，重点加仓二线",
            "features": {
                "keywords": [
                    "北向资金",
                    "白酒",
                    "加仓",
                    "二线"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金动向盘点：白酒抱团强化，重点加仓二线",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "北向资金回归动向：继续增持酿酒行业 减持医药制造行业 减持股份",
            "features": {
                "keywords": [
                    "北向资金",
                    "酿酒行业",
                    "医药制造",
                    "减持"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "酿酒",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金回归动向：继续增持酿酒行业 减持医药制造行业 减持股份",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]